Market Overview:
The global FUT3 protein market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for FUT3 protein from bio-science companies, hospitals and clinics, universities and institutions, and others. Additionally, the growing awareness about benefits of using FUT3 protein is also contributing to the growth of this market. However, factors such as high cost of production and lack of skilled professionals are restraining the growth of this market.
 FUT3 Protein Industry Outlook.svg)
Product Definition:
A protein that helps to add a sugar molecule called fucose to other proteins. This process is called glycosylation and is important for the function of many proteins in the body. Fucosyltransferase 3 (enzyme) FUT3 Protein is involved in glycosylation of cell surface receptors, which are important for communication between cells.
Human:
Human Fucosyltransferase 3 (hFUT3) is a protein that in humans is encoded by the UT gene located on chromosome 17. The hFUT3 enzyme acts as a building block for the human blood sugar (HBSS) and facilitates the transfer of fucose from external sources to certain internal organs, including kidney, liver, and heart. This process helps maintain normal blood glucose levels in humans.
Others:
Others are the other co-products of a particular process or activity. The Others segment includes products such as nucleotides, amino acids, and others that are produced during the purification of a particular protein or during proteolytic processing. The Others segment is expected to grow at an estimated CAGR of XX% in terms revenue owing to its increasing usage in pharmaceuticals and biotechnology industries for research purposes.
Application Insights:
BioScience companies, hospitals and clinics, and universities and institutions were some of the major application sectors. In 2017, the bio science companies segment dominated the global Fucosyltransferase 3 (enzyme) FUT3 protein market accounting for a share of over 40% in terms of revenue. This is due to rising demand for enzyme replacement therapy products from patients with life-threatening diseases caused by a deficiency in one or more fucose pathway enzymes.
The product finds extensive use in research laboratories across colleges and universities as well as industrial settings where high Throughputs are required for screening large numbers of compounds/molecules. The rapid growth of biotechnology sector along with increasing R&D activities at various institutions has led to an increased requirement for these labs to perform their functions effectively under budget constraints & limited space conditions at smaller scale which is expected to drive demand over next few years.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period owing to high demand for diagnostic and research products from a large number of companies located within this region. In addition, increasing prevalence of cancer and other diseases has led to an increase in product demand from oncology drug manufacturers as well as researchers based within North America.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as favorable government initiatives pertaining towards R&D investments, increase in healthcare spending by foreign players along with domestic ones, rise in disposable income levels among middle-class populations coupled with growing awareness about early diagnosis & treatment options are some major factors driving regional growth. Moreover, rising incidence rates of lifestyle-related diseases have also increased product demand within Asia Pacific FUT3 protein market space (35%).
Growth Factors:
- Increasing demand for biologics and monoclonal antibodies from the pharmaceutical and biotechnology industries
- Growing prevalence of cancer and other diseases that can be treated with FUT3 Protein therapies
- Rising public and private investment in research on FUT3 Protein-based therapeutics
- Advances in genomics that are uncovering new therapeutic targets for FUT3 Protein drugs
- The launch of new products by key players in the market
Scope Of The Report
Report Attributes
Report Details
Report Title
Fucosyltransferase 3 (enzyme) FUT3 Protein Market Research Report
By Type
Human, Others
By Application
BioScience Companies, Hospitals and Clinics, University and Institutions, Others
By Companies
RandD Systems, Novus Biologicals, Labome, Merck, Fisher Scientific, MyBioSource, RayBiotech, Sigmaaldrich, RandD Systems
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Fucosyltransferase 3 (enzyme) FUT3 Protein Market Report Segments:
The global Fucosyltransferase 3 (enzyme) FUT3 Protein market is segmented on the basis of:
Types
Human, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
BioScience Companies, Hospitals and Clinics, University and Institutions, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- RandD Systems
- Novus Biologicals
- Labome
- Merck
- Fisher Scientific
- MyBioSource
- RayBiotech
- Sigmaaldrich
- RandD Systems
 FUT3 Protein Market Overview.svg)
Highlights of The Fucosyltransferase 3 (enzyme) FUT3 Protein Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human
- Others
- By Application:
- BioScience Companies
- Hospitals and Clinics
- University and Institutions
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fucosyltransferase 3 (enzyme) FUT3 Protein Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 FUT3 Protein Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fucosyltransferase 3 is an enzyme that helps to transfer the sugar fucose from one molecule of glucose to another. This process is important for the body's ability to make new cells and proteins.
Some of the major companies in the fucosyltransferase 3 (enzyme) fut3 protein market are RandD Systems, Novus Biologicals, Labome, Merck, Fisher Scientific, MyBioSource, RayBiotech, Sigmaaldrich, RandD Systems.
The fucosyltransferase 3 (enzyme) fut3 protein market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Fucosyltransferase 3 (enzyme) FUT3 Protein Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Fucosyltransferase 3 (enzyme) FUT3 Protein Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Fucosyltransferase 3 (enzyme) FUT3 Protein Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Fucosyltransferase 3 (enzyme) FUT3 Protein Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size & Forecast, 2018-2028
4.5.1 Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size and Y-o-Y Growth
4.5.2 Fucosyltransferase 3 (enzyme) FUT3 Protein Market Absolute $ Opportunity
Chapter 5 Global Fucosyltransferase 3 (enzyme) FUT3 Protein Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Type
5.2.1 Human
5.2.2 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Fucosyltransferase 3 (enzyme) FUT3 Protein Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Applications
6.2.1 BioScience Companies
6.2.2 Hospitals and Clinics
6.2.3 University and Institutions
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Fucosyltransferase 3 (enzyme) FUT3 Protein Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Fucosyltransferase 3 (enzyme) FUT3 Protein Analysis and Forecast
9.1 Introduction
9.2 North America Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Type
9.6.1 Human
9.6.2 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Applications
9.10.1 BioScience Companies
9.10.2 Hospitals and Clinics
9.10.3 University and Institutions
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Fucosyltransferase 3 (enzyme) FUT3 Protein Analysis and Forecast
10.1 Introduction
10.2 Europe Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Type
10.6.1 Human
10.6.2 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Applications
10.10.1 BioScience Companies
10.10.2 Hospitals and Clinics
10.10.3 University and Institutions
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Fucosyltransferase 3 (enzyme) FUT3 Protein Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Type
11.6.1 Human
11.6.2 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Applications
11.10.1 BioScience Companies
11.10.2 Hospitals and Clinics
11.10.3 University and Institutions
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Fucosyltransferase 3 (enzyme) FUT3 Protein Analysis and Forecast
12.1 Introduction
12.2 Latin America Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Type
12.6.1 Human
12.6.2 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Applications
12.10.1 BioScience Companies
12.10.2 Hospitals and Clinics
12.10.3 University and Institutions
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Fucosyltransferase 3 (enzyme) FUT3 Protein Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Type
13.6.1 Human
13.6.2 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Fucosyltransferase 3 (enzyme) FUT3 Protein Market Size Forecast by Applications
13.10.1 BioScience Companies
13.10.2 Hospitals and Clinics
13.10.3 University and Institutions
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Fucosyltransferase 3 (enzyme) FUT3 Protein Market: Competitive Dashboard
14.2 Global Fucosyltransferase 3 (enzyme) FUT3 Protein Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 RandD Systems
14.3.2 Novus Biologicals
14.3.3 Labome
14.3.4 Merck
14.3.5 Fisher Scientific
14.3.6 MyBioSource
14.3.7 RayBiotech
14.3.8 Sigmaaldrich
14.3.9 RandD Systems
